You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沃森生物(300142.SZ)擬設立昆明沃森實施募投項目
格隆匯 03-20 21:22

格隆匯3月20日丨沃森生物(300142.SZ)公佈,2020年3月19日,公司第四屆董事會第七次會議審議通過了《關於設立全資子公司實施募集資金投資項目的議案》。為便於沃森生物科技創新中心項目統一管理,更好地推進項目的實施,公司擬設立全資子公司昆明沃森生物技術有限公司(“昆明沃森”),將“沃森生物科技創新中心項目”的實施主體由公司調整為全資子公司昆明沃森。

“沃森生物科技創新中心項目”計劃投入的募集資金1.6億元公司將根據項目的實施進度分次投入昆明沃森(含昆明沃森首次設立時認繳出資5000萬元),由昆明沃森在招商銀行股份有限公司昆明分行廣福路支行(“招商銀行”)開立募集資金專用賬户並與相關各方簽署募集資金監管協議,以確保本募投項目的順利實施。

公司本次將“沃森生物科技創新中心項目”的實施主體由公司調整為全資子公司昆明沃森不屬於《深圳證券交易所創業板上市公司規範運作指引》規定的變更募集資金投資項目實施主體的情形,該事項屬於公司董事會審議權限範圍,無需提交公司股東大會審議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account